Miles D. White - 10 Nov 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship
EXECUTIVE CHAIRMAN, Director
Issuer ticker
ABT
Reported as of
10 Nov 2021
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
08 Dec 2021, 16:36:34 UTC
Prior SEC filing
13 Aug 2021
Next SEC filing
04 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Miles D. White by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Miles D. White filed Form 4 for ABBOTT LABORATORIES (ABT) on 08 Dec 2021.

Key facts

  • This page summarizes Miles D. White's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 08 Dec 2021, 16:36.

Change

  • Previous filing in this sequence was filed on 13 Aug 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Gift

Transaction value
$0
Shares
-693
Change %
-0.02%
Price
$0.000000
Shares after
3,103,252
Date
10 Nov 2021
Ownership
Direct
ABT transaction

Common shares without par value

Gift

Transaction value
$0
Shares
-10,400
Change %
-0.34%
Price
$0.000000
Shares after
3,092,852
Date
12 Nov 2021
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,789
Date
10 Nov 2021
Ownership
Profit Sharing Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance in the Abbott Laboratories Stock Retirement Trust as of December 6, 2021.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .